GAMMA Investing’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

GAMMA Investing’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26	Closed	-$554	–	3534
2024 Q1	$554	Buy	+26	New	+$311	﹤0.01%	3088

GAMMA Investing's FUSN Position: Q2 2024 in Review

GAMMA Investing sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 26 shares — an estimated $554 sold.

GAMMA Investing first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $554 in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

GAMMA Investing reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
GAMMA Investing sold 26 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $554.
GAMMA Investing first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
GAMMA Investing's Fusion Pharmaceuticals Inc. Common Shares position peaked at $554 in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on GAMMA Investing's 13F filing for Q2 2024, filed 2 Jul 2024.